2023-02-012024-01-312024-01-31false13116130TEKKPRO LIMITED2025-02-14falseiso4217:GBPxbrli:pure131161302023-02-01131161302024-01-31131161302023-02-012024-01-31131161302022-02-01131161302023-01-31131161302022-02-012023-01-3113116130bus:SmallEntities2023-02-012024-01-3113116130bus:AuditExempt-NoAccountantsReport2023-02-012024-01-3113116130bus:FullAccounts2023-02-012024-01-3113116130bus:PrivateLimitedCompanyLtd2023-02-012024-01-3113116130core:WithinOneYear2024-01-3113116130core:AfterOneYear2024-01-3113116130core:WithinOneYear2023-01-3113116130core:AfterOneYear2023-01-3113116130core:ShareCapital2024-01-3113116130core:SharePremium2024-01-3113116130core:RevaluationReserve2024-01-3113116130core:OtherReservesSubtotal2024-01-3113116130core:RetainedEarningsAccumulatedLosses2024-01-3113116130core:ShareCapital2023-01-3113116130core:SharePremium2023-01-3113116130core:RevaluationReserve2023-01-3113116130core:OtherReservesSubtotal2023-01-3113116130core:RetainedEarningsAccumulatedLosses2023-01-3113116130core:LandBuildings2024-01-3113116130core:PlantMachinery2024-01-3113116130core:Vehicles2024-01-3113116130core:FurnitureFittings2024-01-3113116130core:OfficeEquipment2024-01-3113116130core:NetGoodwill2024-01-3113116130core:IntangibleAssetsOtherThanGoodwill2024-01-3113116130core:ListedExchangeTraded2024-01-3113116130core:UnlistedNon-exchangeTraded2024-01-3113116130core:LandBuildings2023-01-3113116130core:PlantMachinery2023-01-3113116130core:Vehicles2023-01-3113116130core:FurnitureFittings2023-01-3113116130core:OfficeEquipment2023-01-3113116130core:NetGoodwill2023-01-3113116130core:IntangibleAssetsOtherThanGoodwill2023-01-3113116130core:ListedExchangeTraded2023-01-3113116130core:UnlistedNon-exchangeTraded2023-01-3113116130core:LandBuildings2023-02-012024-01-3113116130core:PlantMachinery2023-02-012024-01-3113116130core:Vehicles2023-02-012024-01-3113116130core:FurnitureFittings2023-02-012024-01-3113116130core:OfficeEquipment2023-02-012024-01-3113116130core:NetGoodwill2023-02-012024-01-3113116130core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3113116130core:ListedExchangeTraded2023-02-012024-01-3113116130core:UnlistedNon-exchangeTraded2023-02-012024-01-3113116130core:MoreThanFiveYears2023-02-012024-01-3113116130core:Non-currentFinancialInstruments2024-01-3113116130core:Non-currentFinancialInstruments2023-01-3113116130dpl:CostSales2023-02-012024-01-3113116130dpl:DistributionCosts2023-02-012024-01-3113116130core:LandBuildings2023-02-012024-01-3113116130core:PlantMachinery2023-02-012024-01-3113116130core:Vehicles2023-02-012024-01-3113116130core:FurnitureFittings2023-02-012024-01-3113116130core:OfficeEquipment2023-02-012024-01-3113116130dpl:AdministrativeExpenses2023-02-012024-01-3113116130core:NetGoodwill2023-02-012024-01-3113116130core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3113116130dpl:GroupUndertakings2023-02-012024-01-3113116130dpl:ParticipatingInterests2023-02-012024-01-3113116130dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012024-01-3113116130core:ListedExchangeTraded2023-02-012024-01-3113116130dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012024-01-3113116130core:UnlistedNon-exchangeTraded2023-02-012024-01-3113116130dpl:CostSales2022-02-012023-01-3113116130dpl:DistributionCosts2022-02-012023-01-3113116130core:LandBuildings2022-02-012023-01-3113116130core:PlantMachinery2022-02-012023-01-3113116130core:Vehicles2022-02-012023-01-3113116130core:FurnitureFittings2022-02-012023-01-3113116130core:OfficeEquipment2022-02-012023-01-3113116130dpl:AdministrativeExpenses2022-02-012023-01-3113116130core:NetGoodwill2022-02-012023-01-3113116130core:IntangibleAssetsOtherThanGoodwill2022-02-012023-01-3113116130dpl:GroupUndertakings2022-02-012023-01-3113116130dpl:ParticipatingInterests2022-02-012023-01-3113116130dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-012023-01-3113116130core:ListedExchangeTraded2022-02-012023-01-3113116130dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-012023-01-3113116130core:UnlistedNon-exchangeTraded2022-02-012023-01-3113116130core:NetGoodwill2024-01-3113116130core:IntangibleAssetsOtherThanGoodwill2024-01-3113116130core:LandBuildings2024-01-3113116130core:PlantMachinery2024-01-3113116130core:Vehicles2024-01-3113116130core:FurnitureFittings2024-01-3113116130core:OfficeEquipment2024-01-3113116130core:AfterOneYear2024-01-3113116130core:WithinOneYear2024-01-3113116130core:ListedExchangeTraded2024-01-3113116130core:UnlistedNon-exchangeTraded2024-01-3113116130core:ShareCapital2024-01-3113116130core:SharePremium2024-01-3113116130core:RevaluationReserve2024-01-3113116130core:OtherReservesSubtotal2024-01-3113116130core:RetainedEarningsAccumulatedLosses2024-01-3113116130core:NetGoodwill2023-01-3113116130core:IntangibleAssetsOtherThanGoodwill2023-01-3113116130core:LandBuildings2023-01-3113116130core:PlantMachinery2023-01-3113116130core:Vehicles2023-01-3113116130core:FurnitureFittings2023-01-3113116130core:OfficeEquipment2023-01-3113116130core:AfterOneYear2023-01-3113116130core:WithinOneYear2023-01-3113116130core:ListedExchangeTraded2023-01-3113116130core:UnlistedNon-exchangeTraded2023-01-3113116130core:ShareCapital2023-01-3113116130core:SharePremium2023-01-3113116130core:RevaluationReserve2023-01-3113116130core:OtherReservesSubtotal2023-01-3113116130core:RetainedEarningsAccumulatedLosses2023-01-3113116130core:NetGoodwill2022-02-0113116130core:IntangibleAssetsOtherThanGoodwill2022-02-0113116130core:LandBuildings2022-02-0113116130core:PlantMachinery2022-02-0113116130core:Vehicles2022-02-0113116130core:FurnitureFittings2022-02-0113116130core:OfficeEquipment2022-02-0113116130core:AfterOneYear2022-02-0113116130core:WithinOneYear2022-02-0113116130core:ListedExchangeTraded2022-02-0113116130core:UnlistedNon-exchangeTraded2022-02-0113116130core:ShareCapital2022-02-0113116130core:SharePremium2022-02-0113116130core:RevaluationReserve2022-02-0113116130core:OtherReservesSubtotal2022-02-0113116130core:RetainedEarningsAccumulatedLosses2022-02-0113116130core:AfterOneYear2023-02-012024-01-3113116130core:WithinOneYear2023-02-012024-01-3113116130core:Non-currentFinancialInstrumentscore:CostValuation2023-02-012024-01-3113116130core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-012024-01-3113116130core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-012024-01-3113116130core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-012024-01-3113116130core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-012024-01-3113116130core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-012024-01-3113116130core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3113116130core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3113116130core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3113116130core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3113116130core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3113116130core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3113116130core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3113116130core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3113116130core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3113116130core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3113116130core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3113116130core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3113116130core:Non-currentFinancialInstrumentscore:CostValuation2023-01-3113116130core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-3113116130core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-3113116130core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-3113116130core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-3113116130core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-3113116130core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-3113116130core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-3113116130core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-3113116130bus:Director12023-02-012024-01-3113116130bus:Director22023-02-012024-01-3113116130bus:Director32023-02-012024-01-3113116130bus:Director42023-02-012024-01-3113116130bus:Director52023-02-012024-01-31131161301bus:Director52023-02-01131161301bus:Director52023-02-012024-01-31131161301bus:Director52024-01-31131161302bus:Director42023-02-01131161302bus:Director42023-02-012024-01-31131161302bus:Director42024-01-31131161302023-02-01131161302023-02-012024-01-31131161302024-01-31

TEKKPRO LIMITED

Registered Number
13116130
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2024

TEKKPRO LIMITED
Company Information
for the year from 1 February 2023 to 31 January 2024

Directors

D R COX
I S R FRANSES
Mrs A P LACEY
C K TUNNICLIFFE
LACEY HOUND MEDICARE LIMITED

Registered Address

7 Albion Close
London
W2 2AT

Registered Number

13116130 (England and Wales)
TEKKPRO LIMITED
Balance Sheet as at
31 January 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets3260,973211,324
260,973211,324
Current assets
Debtors4-45
Cash at bank and on hand167100
167145
Creditors amounts falling due within one year5(153,332)(98,892)
Net current assets (liabilities)(153,165)(98,747)
Total assets less current liabilities107,808112,577
Creditors amounts falling due after one year6-(300,000)
Net assets107,808(187,423)
Capital and reserves
Called up share capital200200
Share premium222,338168,834
Profit and loss account(114,730)(356,457)
Shareholders' funds107,808(187,423)
The financial statements were approved and authorised for issue by the Board of Directors on 14 February 2025, and are signed on its behalf by:
I S R FRANSES
Director
Registered Company No. 13116130
TEKKPRO LIMITED
Notes to the Financial Statements
for the year ended 31 January 2024

1.Accounting policies
Statutory information
TEKKPRO LIMITED is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page. The presentation currency of the financial statements is the Pound Sterling (£).
Basis of preparation
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
Going concern
The financial statements have been prepared on a going concern basis, notwithstanding net current liabilities. The directors of the company has provided the company with an undertaking that it will continue to support the company financially for the foreseeable future and at least 12 months from the date of approval of the accounts.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current or deferred taxation assets and liabilities are not discounted. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Intangible assets
The intangible asset addition during the financial year which relates to the development of the software was not completed as at the date of financial statements, accordingly no amortisation has been charged.
2.Average number of employees

20242023
Average number of employees during the year45
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 February 23211,324211,324
Additions49,64949,649
At 31 January 24260,973260,973
Net book value
At 31 January 24260,973260,973
At 31 January 23211,324211,324
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables-45
Total-45
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables151,83297,392
Accrued liabilities and deferred income1,5001,500
Total153,33298,892
6.Creditors: amounts due after one year

2024

2023

££
Trade creditors / trade payables-300,000
Total-300,000
7.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
LACEY HOUND MEDICARE LIMITED17,6620017,662
C K TUNNICLIFFE6556,986457,596
18,3176,9864525,258
8.Share capital
20,000 Ordinary shares of 0.01 each were issued, as fully paid. 2024 £200 (2023: £200)
9.Related party transactions
Other creditor includes following, by virtue of common control: Bracket Media Limited £2,867 (2023: £Nil) VUUG Limited £4,497 (2023: £Nil) Lacey Hound Medicare Limited £17,662 (2023: £17,662).